Vijay Mishra

Prof. Dr. Vijay Mishra

School of Pharmaceutical Sciences, Lovely Professional University, Phagwara (Punjab), India
orcid

Research Focus & Metrics

Academic Career Length

18Years (2009-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
18 October 2018 in Pharmaceutics
Verified
Journal Article
Open access
PDF file
VMVijay Mishra
Vijay Mishra
Kuldeep BansalKuldeep Bansal
Kuldeep Bansal
AVAsit Verma
Asit Verma
NYNishika Yadav
Nishika Yadav
STSourav Thakur
Sourav Thakur
Jessica M. RosenholmJessica M. Rosenholm
Jessica M. Rosenholm
Solid lipid nanoparticles (SLNs) are nanocarriers developed as substitute colloidal drug delivery systems parallel to liposomes, lipid emulsions, polymeric nanoparticles, and so forth. Owing to their unique size dependent properties and ability to incorporate drugs, SLNs present an opportunity to build up new therapeutic prototypes for drug delivery and targeting. SLNs hold great potential for attaining the goal of targeted and controlled drug delivery, which currently draws the interest of researchers worldwide. The present review sheds light on different aspects of SLNs including fabrication and characterization techniques, formulation variables, routes of administration, surface modifications, toxicity, and biomedical applications.

Verified
Journal Article
Open access
PDF file
AHAlejandro Hurtado
Alejandro Hurtado
Alaa A. A. AljabaliAlaa A. A. Aljabali
Alaa A. A. Aljabali
VMVijay Mishra
Vijay Mishra
Murtaza TambuwalaMurtaza Tambuwala
Murtaza Tambuwala
Ángel Serrano-ArocaÁngel Serrano-Aroca
Ángel Serrano-Aroca
Alginate is an excellent biodegradable and renewable material that is already used for a broad range of industrial applications, including advanced fields, such as biomedicine and bioengineering, due to its excellent biodegradable and biocompatible properties. This biopolymer can be produced from brown algae or a microorganism culture. This review presents the principles, chemical structures, gelation properties, chemical interactions, production, sterilization, purification, types, and alginate-based hydrogels developed so far. We present all of the advanced strategies used to remarkably enhance this biopolymer’s physicochemical and biological characteristics in various forms, such as injectable gels, fibers, films, hydrogels, and scaffolds. Thus, we present here all of the material engineering enhancement approaches achieved so far in this biopolymer in terms of mechanical reinforcement, thermal and electrical performance, wettability, water sorption and diffusion, antimicrobial activity, in vivo and in vitro biological behavior, including toxicity, cell adhesion, proliferation, and differentiation, immunological response, biodegradation, porosity, and its use as scaffolds for tissue engineering applications. These improvements to overcome the drawbacks of the alginate biopolymer could exponentially increase the significant number of alginate applications that go from the paper industry to the bioprinting of organs.

Verified
Journal Article
Open access
PDF file
Alaa A. A. AljabaliAlaa A. A. Aljabali
Alaa A. A. Aljabali
MOMohammad Obeid
Mohammad Obeid
RBRasha M. Bashatwah
Rasha M. Bashatwah
Ángel Serrano-ArocaÁngel Serrano-Aroca
Ángel Serrano-Aroca
VMVijay Mishra
Vijay Mishra
Murtaza TambuwalaMurtaza Tambuwala
Murtaza Tambuwala
Nanomaterials have been the focus of intensive development and research in the medical and industrial sectors over the past several decades. Some studies have found that these compounds can have a detrimental impact on living organisms, including their cellular components. Despite the obvious advantages of using nanomaterials in a wide range of applications, there is sometimes skepticism caused by the lack of substantial proof that evaluates potential toxicities. The interactions of nanoparticles (NPs) with cells of the immune system and their biomolecule pathways are an area of interest for researchers. It is possible to modify NPs so that they are not recognized by the immune system or so that they suppress or stimulate the immune system in a targeted manner. In this review, we look at the literature on nanomaterials for immunostimulation and immunosuppression and their impact on how changing the physicochemical features of the particles could alter their interactions with immune cells for the better or for the worse (immunotoxicity). We also look into whether the NPs have a unique or unexpected (but desired) effect on the immune system, and whether the surface grafting of polymers or surface coatings makes stealth nanomaterials that the immune system cannot find and get rid of.

1 June 2018 in Drug Discovery Today
Verified
Journal Article
Closed access
VMVijay Mishra
Vijay Mishra
APAkshay Patil
Akshay Patil
STSourav Thakur
Sourav Thakur
PKPrashant Kesharwani
Prashant Kesharwani

27 July 2018 in Expert Opinion on Drug Delivery
Verified
Journal Article
Closed access
VMVijay Mishra
Vijay Mishra
STSourav Thakur
Sourav Thakur
APAkshay Patil
Akshay Patil
ASAnshuman Shukla
Anshuman Shukla
Introduction: Quality by design (QbD) encourages the pharmaceutical industry to use risk management and science-based manufacturing principles to gain process and product understanding and thus assures quality of the product. With the objective to curb the rising costs for development and regulatory barriers to innovation and creativity, QbD is being widely promoted by Food and Drug Administration (FDA) and International Conference on Harmonization (ICH). Areas covered: This review describes the elements, different design and tools of QbD as well as multidimensional applications of QbD ranging from dosage form and method development to meeting latest regulatory requirements. Expert opinion: The understanding of a process is facilitated by proper identification of sources of variation, management of variability by process design, and prediction of product quality attributes using design space. The pharmaceutical industry is rapidly adopting the QbD principles for fabrication of safe, effective and quality products; however, we are still on a journey and the process of gathering all experience and metrics required for connecting and demonstrating QbD benefits to all stakeholders is still in progress. Understanding the formulation and process parameters with the philosophy of QbD will be useful for the optimization of complex drug delivery systems in the near future.

6 January 2013 in Expert Opinion on Drug Delivery
Verified
Journal Article
Closed access
NJNarendra K Jain
Narendra K Jain
VMVijay Mishra
Vijay Mishra
NMNeelesh Kumar Mehra
Neelesh Kumar Mehra
Introduction: Targeted drug delivery to the macrophages appears to be an attractive proposition to improve therapeutic efficacy of enclosed drug. Thus, macrophages can be exploited as Trojan horses for targeted drug delivery. Nanocarriers can migrate across the different membrane barriers and release their drug cargo at sites of infection. Areas covered: This review discusses the current status and utilization of various micro- as well as nanocarriers like microspheres/microparticles, liposomes, nanoparticles, dendrimers, niosomes, and carbon nanotubes for targeted delivery of bioactives to the macrophages. Expert opinion: The design of nanocarriers for cell-mediated drug delivery may differ from those used for conventional drug delivery systems. The literature review shows that nanocarriers could supplement sustained drug delivery to the macrophages, extended duration of action, reduced therapeutic dose, improved patient compliance, and reduced adverse effects of highly toxic, potent drugs. There is still a need to identify more specific receptors that are responsible for macrophage targeting. The identification of such receptors may also facilitate drug targeting to further specific parts of the body containing different types of macrophages.